MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with P

Pyridostigmine

Pyridostigmine bromide 10mg tablets

No stability information

Stability notes for Pyridostigmine bromide 10mg tablets

There are no stability notes for this medicine.

Supplier

Pyridostigmine bromide 10mg tablets (Special Order)

Pyridostigmine bromide 60mg tablets

No stability information

Stability notes for Pyridostigmine bromide 60mg tablets

There are no stability notes for this medicine.

Suppliers (9) of Pyridostigmine bromide 60mg tablets
Mestinon 60mg tablets (CST Pharma Ltd)
Mestinon 60mg tablets (Lexon (UK) Ltd)
Mestinon 60mg tablets (Necessity Supplies Ltd)
Mestinon 60mg tablets (Viatris UK Healthcare Ltd)
Pyridostigmine bromide 60mg tablets (A A H Pharmaceuticals Ltd)
Pyridostigmine bromide 60mg tablets (Alliance Healthcare (Distribution) Ltd)
Pyridostigmine bromide 60mg tablets (Flynn Pharma Ltd)
Pyridostigmine bromide 60mg tablets (Medihealth (Northern) Ltd)
Pyridostigmine bromide 60mg tablets (Teva UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.